AbbVie Inc. (ABBV) operating KPIs

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value

$294.89+4.10 (+1.41%)

Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%

AbbVie income tax expense ($M) ($M)

Form 10-Q / 10-K

Quarterly Annual

Latest, FY2025

2,364

Period ended Dec 31, 2025

Change on a year earlier

-514.7%

-570 in FY2024

History

15 years

Since FY2011

Sources

Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Period	Ended	Income tax expense ($M) ($M)	Year on year	Source
FY2025	Dec 31, 2025	2,364	-514.7%	Form 10-K (filed 2026-02-20) ↗
FY2024	Dec 31, 2024	-570	-141.4%	Form 10-K (filed 2025-02-14) ↗
FY2023	Dec 31, 2023	1,377	-15.6%	Form 10-K (filed 2024-02-20) ↗
FY2022	Dec 31, 2022	1,632	+13.3%	Form 10-K (filed 2023-02-17) ↗
FY2021	Dec 31, 2021	1,440	-217.6%	Form 10-K (filed 2022-02-18) ↗
FY2020	Dec 31, 2020	-1,224	-325.0%	Form 10-K (filed 2021-02-19) ↗
FY2019	Dec 31, 2019	544	-211.0%	Form 10-K (filed 2020-02-21) ↗
FY2018	Dec 31, 2018	-490	-120.3%	Form 10-K (filed 2019-02-27) ↗
FY2017	Dec 31, 2017	2,418	+25.2%	Form 10-K (filed 2018-02-16) ↗
FY2016	Dec 31, 2016	1,931	+28.6%	Form 10-K (filed 2017-02-17) ↗
FY2015	Dec 31, 2015	1,501	+152.3%	Form 10-K (filed 2016-02-19) ↗
FY2014	Dec 31, 2014	595	-50.6%	Form 10-K (filed 2015-02-20) ↗
FY2013	Dec 31, 2013	1,204	+167.6%	Form 10-K (filed 2014-02-21) ↗
FY2012	Dec 31, 2012	450	+91.5%	Form 10-K (filed 2014-02-21) ↗
FY2011	Dec 31, 2011	235	–	Form 10-K (filed 2014-02-21) ↗

Cite this data

StockData. (2026). AbbVie Income tax expense ($M) ($M), annual FY2011–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/fs_tax

See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.